From: Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer
 | N = 25 | ||
---|---|---|---|
N | (%) | ||
Age (years) | |||
 | Median | 51 | |
Range | 31–72 | ||
Preoperative serum CA-125 level (U/ml)* | |||
 | Median | 79.6 | |
Range | 18.9–428.5 | ||
ECOG performance status | |||
 | 0 | 16 | 64 |
1 | 9 | 36 | |
FIGO stage | |||
 | I A | 4 | 16 |
I C | 7 | 28 | |
II B | 2 | 8 | |
III A | 1 | 4 | |
III C | 10 | 40 | |
IV A | 1 | 4 | |
Primary tumor site | |||
 | Ovary | 21 | 84 |
Peritoneum | 3 | 12 | |
Fallopian tube | 1 | 4 | |
Histology | |||
 | High-grade serous carcinoma | 12 | 48 |
Endometrioid carcinoma | 5 | 20 | |
Clear cell carcinoma | 7 | 28 | |
Others** | 1 | 4 | |
Supra-renal PAN enlargement on CT*** | |||
 | Yes | 2 | 8 |
No | 23 | 92 | |
Ascites at laparotomy | |||
 | Yes | 11 | 44 |
No | 14 | 56 | |
Timing of surgery | |||
 | PDS or staging | 15 | 60 |
NAC-IDS*** | 10 | 40 | |
Operative procedures | |||
 | TH+BSO | 25 | 100 |
Omentectomy | 25 | 100 | |
Pelvic lymphadenectomy | 25 | 100 | |
Para-aortic lymphadenectomy | 25 | 100 | |
Pelvic peritoneum stripping | 10 | 40 | |
Abdominal peritoneum stripping | 11 | 44 | |
Recto-sigmoidectomy/anastomosis | 1 | 4 | |
Large bowel resection | 1 | 4 | |
Diaphragm stripping/resection | 8 | 32 | |
Splenectomy | 1 | 4 | |
Liver resection | 1 | 4 | |
Small bowel resection | 1 | 4 | |
Residual tumors | |||
 | No macroscopic residual tumor | 20 | 80 |
Smaller than 1 cm in diameter | 5 | 20 | |
UICC TNM | |||
 | pT1 | 12 | 48 |
pT2 | 2 | 8 | |
pT3 or ypT3 | 11 | 44 | |
No. of dissected lymph nodes | |||
 PLN | |||
 | Median | 26 | |
Range | 14–55 | ||
Infra-renal PAN | |||
 | Median | 21 | |
Range | 12–36 | ||
Supra-renal PAN | |||
 | Median | 5 | |
Range | 2–10 |